ASH 2011 Conference Coverage

Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas

In a phase 1 clinical trial, the combination produces a significant and long-lasting response in patients with advanced disease including metastases to the peritoneum and lung.

Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer

The effects of a 2-treatment course of acupuncture on pain, nausea, and anxiety and ability to cope among women undergoing mastectomy was compared with usual care.

Alternating Pazopanib and Everolimus Treatment Schedule Not Effective for RCC

Alternating treatment with pazopanib and everolimus failed to prolong progression-free survival compared with continuous pazopanib.

Adding Onartuzumab to Chemo Not Effective for HER2-, MET+ Gastroesophageal Adenocarcinoma

Adding the mesenchymal-epithelial transition (MET) antibody onartuzumab did not significantly improve clinical outcomes.

Rasburicase More Effective Than Allopurinol for Tumor Lysis Syndrome

In patients with tumor lysis syndrome, rasburicase was significantly more effective in treating hyperuricemia and was associated with significantly shorter ICU stay.

Mental Health Disorder Linked to Poorer Survival in NSCLC

Among patients with non-small cell lung cancer (NSCLC), those with a mental health disorder appeared to have a higher risk of death.

Perindopril, Bisoprolol Not Effective for Preventing Trastuzumab-mediated Left Ventricular Remodeling

Perindopril, an angiotensin-converting enzyme (ACE) inhibitor, and the beta blocker bisoprolol protected against trastuzumab-related declines.

LIVESTRONG Exercise Program Improves QoL in Cancer Survivors

The LIVESTRONG at the YMCA exercise program significantly improved physical activity, fitness, and quality of life in survivors of cancer.

Preventing Tumor Lysis Syndrome in Patients Receiving Venetoclax

What precautions should be taken to prevent tumor lysis syndrome (TLS) in patients receiving venetoclax (Venclexta)?

Thalidomide, Lenalidomide Equivalent With Respect to Survival in Myeloma

Thalidomide and lenalidomide are equivalent with respect to survival outcomes in patients with multiple myeloma.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs